Non-voting agency representatives : 
Joel M. Dalrymple, Department of Defense 
George D. Duda, Department of Energy 
Bernard Greifer, Department of Commerce 
Morris A. Levin, Environmental Protection Agency 
Henry Miller, Food and Drug Administration 
George P. Shibley, Department of Agriculture 
Sue A. Tolin, Department of Agriculture 
National Institutes of Health staff: 
Stanley Barban, NIAID 
Irving Delappe, NIAID 
Rosalind Gray, OD 
John Irwin, OD 
Becky Lawson, NIAID 
Suzanne Varimbi, OD 
Others : 
Elizabeth Anderson, Environmental Protection Agency 
Jarl Anderson, Nova Laboratories, Inc. 
Brian Becker, Blue Sheet 
Carter Blakey, Federation of American Societies for 
Experimental Biology 
Arindam Bose, Pfizer, Inc. 
Kim Brell, Hill and Knowlton 
Theodore J. DeLoggio, Pennwalt Corporation 
Charles J. Eby, Hill and Knowlton 
Carol Ezzell, Nature 
Peter Farnham, American Society for Biochemistry and 
Molecular Biology 
Malcolm Finkelman, Genex Corporation 
Mark A. Foglesong, Eli Lilly and Company 
Joseph R. Fordham, Nova Laboratories, Inc. 
Jeffrey L. Fox 
David E. Giamporcaro, Nash, Railsback, & Plesser 
Richard H. Glover, Food and Drug Administration 
Robert Goldberg, Merck Research Laboratories 
Alan R. Goldhammer, Industrial Biotechnology Association 
Ann Ruth Herkes, German Embassy 
Michael Hyer, StenoTech, Inc. 
John E. Jangstetter, Genentech, Inc. 
Bent F. Jensen, Nova Industri A/S 
Dorothy Jessup, Department of Agriculture 
Chris Joyce, New Scientist Magazine 
Peggy R. Kearney, Biometric Research Institute, Inc. 
A. S. Lubiniecki, Genentech, Inc. 
Jack J. Manis, Upjohn Company 
William L. Muth, Eli Lilly and Company 
Recombinant DNA Research, Volume 13 
[129] 
